arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BeyondSpring Inc.

BYSI
$0.64 0.00 (-0.05%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
20 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

BeyondSpring Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $26.3M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 5.2% ↘
FCF / Share $-0.09 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-849.00K
↑ +53.0% —
FCF / Share Free cash flow per share
$-0.09
↓ -15.1% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —

Health Breakdown

Returns
50
Cash Quality ↑
99

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 12 years · 20 quarters